Teva Pharmaceutical Industries Limited
TEVA
#578
Rank
$44.188 B
Marketcap
Israel
Country
$37.92
Share price
3.95%
Change (1 day)
109.97%
Change (1 year)
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and…
Key Metrics
Trailing P/E
64.25
Forward P/E
12.67
EPS (TTM)
$0.61
Forward EPS
$3.10
Price / Book
5.89
EV / EBITDA
13.8x
Beta
0.87
Dividend Yield
—
Return on Equity
9.69%
Return on Assets
5.13%
Debt / Equity
217.79
Current Ratio
0.88
Gross Margin
52.46%
Operating Margin
4.03%
Net Profit Margin
4.08%
Free Cash Flow
$2.220B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 17
+4.59%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$17.257B
Latest Net Income$1.410B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Teva Pharmaceutical Industries Limited with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
TEVA
No recent news available. Set FINNHUB_API_KEY to enable news.
